Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.

Abstract

BACKGROUND Accurate determination of recipient cytomegalovirus (CMV) serostatus before allogeneic hematopoietic stem cell transplantation (HSCT) is critical, as it is the most important predictor of post-transplant CMV infection and remains associated with non-relapse mortality. The purpose of this study was to assess a recipient dual-testing strategy… (More)
DOI: 10.1111/tid.12591

Topics

Cite this paper

@article{Perry2016AssessmentOA, title={Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.}, author={Daphne A Perry and Morgan Hakki}, journal={Transplant infectious disease : an official journal of the Transplantation Society}, year={2016}, volume={18 5}, pages={809-814} }